Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, January 24, 2018
Imprimis announced its New Jersey FDA-registered outsourcing facility has been issued a DEA Manufacturer Controlled Substance Registration Certificate.
read more
Wednesday, January 24, 2018
API developer and manufacturer, Sterling Pharma Solutions, announced it is expanding its capacity in Japan.
read more
Tuesday, January 23, 2018
Paragon Bioservices announces the expansion of a new process development and cGMP manufacturing facility located near BWI Airport.
read more
Tuesday, January 23, 2018
Under the expanded agreement, ABL will provide development, manufacturing & QC release testing services for SillaJen's pipeline product, JX-970.
read more
Three new chemists have joined Contract Research and Development Organization Arcinova’s Active Pharmaceutical Ingredient team.
read more
Hangzhou Just Biotherapeutics held the grand opening ceremony for its R&D Center and Manufacturing Facility.
read more
Wednesday, January 17, 2018
Cambrex held an opening ceremony with AstraZeneca at its Sweden site to mark the commencement of a long-term manufacturing agreement between the two companies for a key intermediate.
read more
Wednesday, January 17, 2018
Pharmaceutical Product Development and Quotient Sciences announced a new collaboration to accelerate pediatric drug development.
read more
PCI Synthesis announced the company’s president, Ed Price, has joined the Board of Governors of the Society of Chemical Manufacturers and Affiliates (SOCMA).
read more
Wednesday, January 10, 2018
Aimmune Therapeutics announced an expansion and extension of its exclusive supply agreement with Golden Peanut and Tree Nuts, to support AR101.
read more
Wednesday, January 10, 2018
AMRI announced Michael Mulhern has joined the company as chief executive officer, succeeding William S. Marth.
read more
Sharp has completed the first phase in the development of its new USD $23m facility in Bethlehem, PA.
read more
Update from the FDA on the continued efforts to mitigate the IV saline and amino acids for injection shortages exacerbated by Hurricane Maria.
read more
Thursday, January 04, 2018
Beacon Discovery has entered into a collaboration agreement with Janssen Pharmaceuticals.
read more
Wednesday, January 03, 2018
BrainStorm Cell Therapeutics has received GMP approval from the Israel Ministry of Health for its Israeli contract manufacturing facility.
read more